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Abstract
A TRANSCRANIAL DOPPLER STUDY COMPARING CEREBROVASCULAR
REACTIVITY IN PATIENTS WITH ACUTE STROKE AND TRANSIENT
ISCHEMIC ATTACK.
Norman Whitmire, Jr., Frank Pavalkis, Pierre B. Fayad, Erfan A. Albakri, and
Lawrence M. Brass.

Department of Neurology, Yale University School of

Medicine, New Haven, CT.

The autoregulatory capacity of the brain is important to the maintenance of
adequate perfusion in the face of changes in blood pressure or blood oxygen
concentration.

Disruptions of the cerebral vasculature, such as that seen in

stroke and transient ischemic attack (TIA) can create disruption of that
autoregulatory

capacity.

An

understanding of the mechanisms

and

characteristics of cerebral autoregulation may help guide the management of
acute stroke patients and may help in the prevention of stroke in patients with
transient ischemic attack.
Twenty-six patients were studied using transcranial Doppler ultrasound.
Each was given 1 gram of intravenous acetazolamide (Diamox) and monitored
for 30 minutes in order to quantify the cerebrovascular reactivity, which could be
inferred from the increase in blood velocity on TCD.
The stroke patients had significantly lower reactivity on the affected side
than did the TIA patients on the same side (p = 0.02).

Non-lacunar strokes

demonstrated significantly lower reactivity than did lacunar strokes (p = 0.02).
Patients with superficial (cortical) lesions showed significantly lower reactivity
than did those with deep (subcortical) lesions (p = 0.05).

The stroke patients,

those with non-lacunar strokes, and those with superficial lesions demonstrated
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significantly lower reactivities (p < 0.01 for all three groups), compared to normal
subjects.
Reactivity testing in cerebrovascular disease may be useful in guiding acute
management and in screening for stroke.

1

1.

Introduction & Literature Review

1.1

Introduction

The brain is absolutely vital to the independent survival of all human beings. Its
proper functioning depends on an adequate supply of oxygen and glucose.
Despite being only 2% of body weight, the brain receives 15% of the total blood
supply (Vander et al., 1985). There are very tight controls on the cerebrovascular
system in order to insure that adequate oxygen will be able to meet the metabolic
needs of the brain at any given time, for a wide range of blood pressures. The
controls are mediated through vascular innervation that also responds to a
number of endogenous vasodilating and vasoconstricting substances.
Disruption of the cerebral vasculature causes dysfunction of this control
mechanism. Atherosclerosis, microvascular changes, like those seen in diabetes,
or vascular defects, such as arteriovenous malformations can affect these vessels'
ability to respond to the appropriate endogenous stimuli. In addition, occlusive
processes, such as a thrombus or an embolus can create a state where vessels are
maximally stimulated and are unable to respond appropriately to blood pressure
changes.
Altered cerebral hemodynamics is an important factor in the pathophysiology
of ischemic diseases of the brain (e.g., transient ischemic attack and stroke). It
affects the cerebrovascular response to blood pressure changes and, thus, the
capability of adequate brain perfusion. Techniques, such as those that measure
cerebrovascular reactivity, can test the reserve capacity of brain vasculature and
provide an idea of how well these blood vessels can autoregulate cerebral blood
flow, especially in the setting of ischemic brain disease.

These techniques

involve the exogenous administration of physiologic substances, like carbon
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dioxide, or drugs (e.g., acetazolamide) which increase the serum concentration of
carbon dioxide. Changes in autoregulatory capacity are easily identified.
Careful monitoring of reactivity may be useful in guiding the therapy and
management of some stroke patients.

Patients in whom reactivity—therefore,

autoregulation—is impaired may require more careful blood pressure control to
insure maximal brain perfusion.

However, as the vasomotor reserve capacity

improves, such tight controls can become more liberal, as the brain vasculature
will be better able to deal with blood pressure changes.
This thesis is a description of research using transcranial Doppler ultrasound
that focuses on changes in cerebrovascular reactivity of patients immediately
following a stroke or transient ischemic attack.

Comparisons were made

between patients with stroke and TIAs, and between the locations of the brain
lesions.

In Chapter 1 of this thesis, some of the previous literature concerning

autoregulation, transcranial Doppler ultrasound, and cerebrovascular reactivity
will be reviewed; this will set the context for the study here.

Chapter 2 will

describe the methods used to conduct this research. The results will be presented
in Chapter 3; a number of tables and graphs have been provided to facilitate
understanding of the findings. Finally, Chapter 4 will be a forum for discussion
of those results and will provide suggestions for future investigations.

1.2

Autoregulation

Autoregulation is the physiological regulatory mechanism that maintains a
constant flow over wide ranges of arterial blood or perfusion pressure.

In the

brain, this can be defined as "the occurrence of vasodilatation in response to a
decrease in cerebral perfusion pressure and the occurrence of vasoconstriction in
response to increased cerebral perfusion pressure" (Paulson et al., 1990).
Autoregulation is dependent on cerebrovascular tone, and demonstrates an

.
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inverse relationship between the rate of regulation and PaC02 (Aaslid et al.,
1989).

Mechanisms of Autoregulation
Paulson et al., 1990 cite four mechanisms of cerebrovascular autoregulation
described in the literature:

myogenic, metabolic, perivascular nerves, and

endothelial cell-related factors.

The first mechanism is the myogenic which

suggests that smooth muscle of the cerebral blood vessels responds to changes in
transmural pressure. The small arteries then constrict or dilate in responses to
increases or decreases in the pressure, respectively. This is facilitated by a change
in the state of actin and myosin filaments in smooth muscle cells.
The second mechanism, the metabolic mechanism suggests that CC>2, H+, O2,
adenosine, adenine, K+ and Ca2+ may serve as mediators in the coupling of
neuronal activity and blood flow. The exact mechanism of this is not known,
however. In addition, the renin-angiotensin system may play a key role in this
by controlling vasoconstriction (Paulson and Waldemar, 1991).
The third mechanism cited is regulation by perivascular nerves. Nerve fibers
which originate from cranial ganglia provide autonomic motor and sensory
input to cerebral blood vessels. At rest the autonomic system has little influence
on cerebral blood flow; autoregulation is maintained by the smaller resistance
vessels. However, when activated by endogenous (e.g. ischemia) or exogenous
(e.g. CO2 and acetazolamide) factors, the upper limits of autoregulation may be
shifted to higher pressures. Conversely, acute denervation may shift the limits
of autoregulation toward lower pressures; chronic stimulation may not have any
effect.
The fourth mechanism cited by Paulson et al. (1990) involves factors released
from endothelial cells. They point out that endothelium-derived relaxing factor

■
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(EDRF) may be released from a blood vessel in response to higher blood flow
within that vessel, causing a vasodilation.
The process of autoregulation is a complex one. Many systems are involved
in its proper functioning. Understanding of how it works can guide therapy and
management in situations where autoregulation is compromised or lost.

1.3
1.3.1

Cerebrovascular Reactivity
General

Carbon dioxide (CO2) is the normal physiological modulator of cerebral blood
flow (CBF) and plays a key role in an exquisite control mechanism. Increases in
arterial blood C02 tension cause marked vasodilation.

In addition, it changes

arteriolar resistance by altering the pH in perivascular and intracellular vascular
smooth muscle. This is possible because C02 can diffuse into the smooth muscle
from brain tissue and from the vessels; hydrogen ions, on the other hand, are
prevented from reaching vascular smooth muscle because of the blood-brain
barrier.

This results in an inverse relationship between cerebral blood vessel

diameter and pH. (Berne and Levy, 1986)
It can be administered exogenously in order to induce vascular changes
associated with hyper- and hypocapnia.

The ratio of percent change in CBF

plotted against the change in pC02 is defined as reactivity (DeWitt et al., 1993).
The figure below is an example of a C02-reactivity plot (adapted from Ringelstein
and Otis, 1992):
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Figure 1-1. Normal vasomotor reactivity using CO2. The x-axis represents the
volume of gas used; the y-axis represents the percent change in velocity from
baseline (100%).

Changes in CBF can be measured by a variety of means, including single¬
photon

emission

computed

tomography

(SFECT),

positron-emission

tomography (PET), and transcranial Doppler ultrasound (TCD) (Rogg et al., 1989).
In the normal patient, hypercapnia should cause an increase in CBF detectable by
PET or SPECT, and a velocity increase by TCD.

A marked decrease in MCA

response to hypercapnia (e.g. in the setting of carotid artery occlusion), suggests a
compensatory vasodilation of vessels distal to the ICA (Bishop et al., 1986), as a
consequence of these resistance vessels being maximally dilated (Ringelstein and
Otis, 1992).

1.3.2

Acetazolamide in Vasomotor Reactivity

Although CO2 is one of the physiologic substances that induces cerebral
vasodilation, acetazolamide (Diamox) produces a similar effect. Acetazolamide
is an inhibitor of carbonic-anhydrase, the enzyme which facilitates the
conversion of CO2 to HC03~ in the proximal tubule of the kidney and in
erythrocytes (Sorteberg et al., 1989; Warnock, 1989).

Inhibition of this enzyme
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results in an increase in the blood concentration of CO2 and mimics the effects of
direct CO2 administration.
The use of acetazolamide has been shown to be as accurate a method of
inducing vasodilation as CO2 in testing cerebrovascular reactivity (Piepgras et al.,
1990; Ringelstein et al., 1992; Sorteberg et al., 1989). It creates a physiologic state
that correlates to the direct inhalation of CO2; however, at least 1 gram of the
drug must be used to equal the same response (Hague et al., 1983; Ringelstein et
al., 1992; Vorstrup et al., 1984). The advantages of using acetazolamide are that it
is easy to administer, is independent of patients cooperation, and less
uncomfortable to the patient.

The disadvantage is that it induces only a

vasodilatory response, so the vasoconstrictive capacity of vessels cannot be
evaluated (Ringelstein et al., 1992).

1.4
Transcranial Doppler Ultrasound
1.4.1 General Principles (Aaslid, 1992; Brass et al., 1989; Caplan et al., 1990;
Tegeler and Eicke, 1993)

The Doppler Principle
Christian A. Doppler (1803-1853), an Austrian physicist, described a wave
principle concerning the relationship between the velocity of moving objects and
the resulting frequencies of the reflected signal. This is given by the formula:

V
f = f2 - f0 = 2 • f0 • c
(f = Doppler shift; f2 = resultant frequency; f0 = incident frequency; V = velocity of object; c = speed of sound)

Basics of Diagnostic Ultrasound
Diagnostic ultrasound takes advantage of this principle by emitting a sound
wave from a transducer at 1 to 20 MHz.

A moving erythrocyte shifts the

■
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frequency in proportion to the velocity.

If blood is moving toward the

transducer, the wave is shortened; conversely, if the blood cell is moving away
from the transducer, the wave is lengthened.

The measured velocity is a

component of the velocity along the line of insonation and is proportional to the
cosine of the angle of insonation (<j>) by the transducer.

Blood flow moving

directly toward the transducer is measured at 1.00 times the real velocity; blood
traveling toward the transducer where <]> = 60° will be measured at 0.5 times the
velocity; and blood moving at an angle of 90° to the transducer will measure a
velocity of zero. Thus, the resultant formula for flow velocity, corrected for <J) is:

c
f
V =-•72 • cos(|) *0

Transcranial Doppler Ultrasound (TCP)
Early Doppler ultrasound devices utilized continuous sound waves pulsed at
2 to 10 MHz.

This technique encountered limitations when attempting to

penetrate the skull, because of impaired impedance coupling1 due to the density
of bone. Aaslid et al., 1982 discovered the technique of using shorter frequency
(1-2 MHz) pulsed waves which penetrate the skull better.

That led to the

development of transcranial Doppler (TCD) ultrasound.
Intracranial arteries can be sonated through a number of "windows" located
at the temporal, occipital, and frontal bones.
approaches used in transcranial investigation:

These correlate with the three
the transtemporal (temporal

squama), transorbital (orbit), and the suboccipital/transnuchal (foramen

1 Impedance coupling is the phenomenon that occurs when sound waves traveling through one
medium encounter a different medium. For example, sound traveling through the ocean will be
heard underwater, but not in the air above; similarly, the reverse is true with regard to sound
traveling through air.

'
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magnum). The arteries that can be insonated through each approach are given
below (adapted from von Reutern and von Biidingen, 1993):

transtemporal-

middle cerebral
terminal segment of the internal carotid
anterior cerebral (A1 segment)
anterior communicating
posterior cerebral (PI and P2 segments)
posterior communicating
superior cerebellar

transorbital-

ophthalmic
internal carotid siphon
anterior cerebral

suboccipital-

vertebral (intracranial portions)
posterior inferior cerebellar
basilar

Identification of Blood Vessels
Individual intracranial blood vessels can be located using four parameters:
adjustment of the angle of insonation, depth of insonation, comparison of the
shape of the wave-form, and the direction of blood flow2.

Normal

Parameters in Identifying the MCA

The middle cerebral artery (MCA) can be easily identified via the
transtemporal window. The transducer should be placed immediately superior
to the zygomatic arch and directed perpendicular to the bone. The MCA is found
at a depth between 35-60 mm with direction of flow moving toward the
transducer. Mean velocities range from 41 to 70 cm/sec and decreases inversely
with age; however, low hematocrit levels may result in velocity increases.

2Above the baseline = toward the transducer; below the baseline = away from the transducer

Chapter 1:
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Resistance should be low with PI of approximately 0.90 ± 25. (Brass et al., 1988;
DeWitt et al., 1993)

1.4.2

Clinical Uses of TCD

Transcranial Doppler ultrasound is a useful technique in evaluating conditions
affecting the cerebrovascular system, and it is commonly used in a wide variety
of settings. The major uses of TCD include the following (adapted from AAN,
1990):

• detection of severe stenosis (>65%) in the major basal intracranial
arteries
• assessment of the patterns and extent of collateral circulation in
patients with known regions of severe stenosis or occlusion
• evaluation and following of patients with vasoconstriction of any
cause, especially after subarachnoid hemorrhage (SAH)
• detection of arteriovenous malformations (AVMs) and the study
of their supplying arteries and flow patterns
• assessment of patients with suspected brain death

Other Possible Uses of TCD
Table 1-1 below lists a number of other situations/disorders where TCD may
be useful:

Disease
AVM
brain death

brain function
dementia

Reference
Lindegaard et al., 1986
Bode et al., 1988
Dernbach, 1989
Newell et al., 1989
Harders et al., 1989
Foerstl et al., 1989

Chapter 1:

migraine

normal pressure
hydrocephalus
pediatrics

post-partem
Shy-Drager syndrome
sickle cell disease
surgery

Giller et al., 1990
Thie et al., 1990
Thie et al., 1990
Fritz et al., 1989
Bode and Harders, 1989
Bode and Eden, 1989
Chadduck et al., 1991
Bogousslavsky et al., 1989
Briebach et al., 1989
Adams et al., 1988
Brass et al., 1991
Awad and Little, 1991
Bass et al., 1989
Benichou et al., 1991
Bernstein, 1990
Brass, 1990
Padayachee et al., 1987

Table 1-1. Other possible situations using TCD.
officially established.

1.4.3
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These uses have not been

Use of TCD in Reactivity Testing

Use in Ischemic Disease
Measurement of cerebrovascular reactivity with TCD is useful in ischemic
disease. As discussed above, resistance arterioles supplying the brain undergo
dilation in response to the hypercapnia associated with ischemia. Reactivity is a
measurement of the vasodilatory response of these vessels in the presence of an
exogenous stimulus, such as CO2 or acetazolamide. This decreased response has
been demonstrated in a number of studies (Kleiser et al., 1991; Ringelstein et al.,
1988; Widder et al., 1994). Transcranial Doppler provides a means of evaluating
reactivity that is non-invasive, portable, and time-saving. The two pages which
follow show examples of a normal (Figure 1-2) and an abnormal (Figure 1-3)
TCD-reactivity tracing.
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Other Uses of Reactivity Studies
Reactivity in number of other settings has also been studied. These include
subarachnoid hemorrhage (Dernbach et ah, 1988; Hassler and Chioffi, 1989;
Romner et al., 1991), migraine (Harer and von, 1991; Thie et al., 1992; Zwetsloot
et al., 1991), various types of surgery (Hartl et al., 1994; Karnik et al., 1992; Lundar
et al., 1985; Russell et al., 1990), head injury (Tenjin et al., 1990), and brain
hemorrhage (Klingelhofer and Sander, 1992).
studies are beyond the scope of this thesis.

The specific findings of these

'

Introduction & Review of The Literature

Pre-acetazolamide
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2.

Methods

Patient Identification and Acquisition
Patients for this study were identified by consulting the admission log for the
Neurology service at Yale-New Haven Hospital.

Those patients who met the

following criteria were placed under further consideration:

• Probable stroke or transient ischemic attack by clinical history and
diagnostic imaging work-up
• No other concurrent medical conditions that might confound the results of
the study (e.g. Severe hypertension)
• Conditions that might be exacerbated by the use of acetazolamide (e.g.
electrolyte imbalance or severe acidosis)

Exclusions were based on the following criteria:

•

Equivocal clinical presentation

•

Poor signals through the transtemporal bone window on either side

•

The reactivity study could not be performed within seven days of the
stroke or TIA

Patients who met the initial inclusion criteria underwent a routine
transcranial Doppler ultrasound study.

If they demonstrated acceptable

transtemporal bone windows that allowed an adequate Doppler signal, they were
then informed of the acetazolamide-reactivity test which would be performed as
an adjunct procedure to the routine TCD study. The procedure was thoroughly
explained to them, making sure they understood the purpose of the test, what to

Chapter 2:
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expect during and following the tests, and the risks of the test. A procedure note
and statement of verbal consent were included in the patient's chart.

Patient Demographics
A total of 61 patients (48 strokes, 13 TIAs) met the initial inclusion criteria. Of
those, 32 subjects (52%) were excluded for a variety of reasons.

Most of the

exclusions were based on inadequate Doppler signals secondary to poor
transtemporal bone windows.

In addition, there was one patient with an

equivocal diagnosis, and one patient whose symptoms were of psychogenic
origin. The remaining exclusions consisted of patients who refused to participate
in the study altogether.

Finally one patient who underwent a complete

acetazolamide-reactivity study had to be excluded after it was discovered that the
wrong blood vessel had been insonated.
We studied 26 patients (15 men, 11 women). The mean patient age for stroke
patients participating in the study was 61 years (s.d. = ±18); among TIA patients,
the mean age was 56 years (±16). These patients were divided by diagnosis (based
on the discharge diagnosis recorded in the medical record) and by lesion site
(based on official CT and/or MRI reports). The distribution of patient diagnoses
is given in table 2.1 below:

Chapter 2:
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Diagnosis

Tvpe

# of Patients

Percent

Stroke

non-lacunar
lacunar
Total

14
4
18

78%
22%
100%

Lesion Site

superficial
deep
combined
Total

9
8
1
18

50%
44%
6%
100%

TIA

Total

8

100%

Total Patients Studied

26

Table 2-1. Demographic information of the patients included in this study.

Transcranial Doppler Equipment

Three different transcranial Doppler (TCD) ultrasound units were used
during the course of this study as the manufacturer developed updated models
and software versions. The first device used was a Transpect TCD (Medasonics,
Mountain View, CA). 12 patients were tested this unit.
The second unit was an updated model, the Medasonics Cerebrovascular
Diagnostic System (CDS), version 1.1.

Improvements were made in signal

clarity, as well as hardware capabilities. 7 patients were tested using this updated
device. The software for this version was updated to version 1.3.6, which further
enhanced the capabilities and clarity of the machine and output. 4 patients were
tested using the newer software.
The last TCD device used was the Medasonics CDS, version 2.1 Bilateral
Doppler System. This updated unit permitted simultaneous bilateral testing. 6
patients were tested using the latter device.

■
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Transducers
Ultrasound signals were generated using a 2 MHz pulsed Doppler transducer.
The pulse repetition frequency is adjustable to 3.9, 5.25, 7.8, or 10.5 kHz by
software under user control. The spatial peak temporal average intensity of the
ultrasound is 161 mW/cm2. Since the first two models permitted only unilateral
testing, two transducers were attached to a switcher box that was manually
alternated between left and right during every minute of testing time.

Attachment of the Transducers
The transducers used with the first TCD unit were specially-designed so that
they could be attached to a helmet that fit around the patient's head. After an
adequate signal was obtained, the transducers were secured with a small screw
located on either side of the helmet.

The test then proceeded.

Transducer

placement had to be carefully monitored to avoid loss of signal if the patient
suddenly moved.
The other two TCD units did not utilize a helmet.

Instead, the transducers

were fixed directly onto the patient either by an elastic band or with surgical
cement.

The elastic band was preferred, because of the extreme difficulty

associated with application and removal of the cement.

Printer
Beginning with the use of the TCD unit CDS, version 1.3.6, studies were
printed using a Hewlett-Packard Printrex 412 thermal printer. Recordings during
the test were first stored on the hard disk and later retrieved and printed for
filing.
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Testing Procedure
The best transtemporal window on each side was located and the middle
cerebral arteries identified first by a hand-held probe; the location was noted
either by placing a pen mark or by the impression left by the conducting gel. The
securable probes were then connected to the machine.

For the Transpect and

earliest CDS Doppler units, the two probes were connected to the switcher box
then the box was connected to the machine.

On the CDS Bilateral Doppler

System the probes could be connected directly to the machine via two ports
located in the back.

Once the MCAs were re-identified, the probes could be

attached as described in the section above.
Prior to the test, baseline velocities were recorded for three to five minutes;
these were averaged to result in one baseline velocity for each side. Although a
single recording may have been sufficient, the average of many recordings was
chosen to reduce the possibility of an aberrant baseline velocity influencing the
outcome of the test.

When the baseline value was recorded, the patient was

given 1 gram of acetazolamide (Diamox) intravenously via the cubital vein or
dorsal vein of the hand, followed by a lOcc saline flush.3 When an intravenous
line or "hep-lock" line was not present, the infusion was done through a
"butterfly" line.
The beginning of infusion was counted as "time zero" (TO). In order to avoid
one data point greatly skewing the outcome, one reading was taken every fifteen
seconds and averaged to obtain the peak (systolic) velocity for that minute. Then
the unit would be switched to measure and readings for the following minute
would be taken in the same manner. This method of alternate minute readings

3Although the preparation, set-up, and testing were all performed by NW (the principal
investigator), the acetazolamide was administered by a licensed physician or certified physician's
associate.
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continued throughout the duration of the examination.

The TCD unit, version

2.1 possessed improved insonation capabilities and accuracy, as well as the ability
for taking simultaneous bilateral Doppler recordings.

Therefore, use of the

alternating method was no longer necessary, and only one reading per minute
was required.

Timing of the Procedure
The time involved for the entire procedure was as follows:
minutes; post-acetazolamide = 25-30 minutes.

baseline = 3-5

The duration of baseline

recordings was chosen in order to reduce the possibility of a skewed value from
an aberrant data point.

The duration of the test following the infusion of

acetazolamide is based on previous studies which demonstrated a rise in systolic
velocity during the first five minutes after giving acetazolamide followed by a
plateauing of the velocity lasting approximately thirty minutes (Hague et al.,
1983; Ringelstein et al., 1992).

Some examinations were terminated early (i.e.,

after 20-25 minutes), however, if the patient became extremely tired or agitated.
One patient became agitated after fifteen minutes, so the study was terminated;
this did not affect the outcome, since the plateau phase had been reached. The
patient suffered no other ill effects.

Recording the Studies
The Medasonics Transpect TCD and the CDS, version 1.1 units were linked to
a Realistic, model 16-616 videocassette recorder and Panasonic WV-5410
monitor. Each study was recorded in its entirety and reviewed after the study to
obtain individual minute readings.

Appropriate labeling was done during the

test so that the correct blood vessel and time could easily be identified.

The

updated CDS, version 1.3.6 and the CDS, version 2.1 (bilateral TCD) did not have

'
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a video board; therefore, studies were recorded on the hard disk drive. These
were retrieved in the office following the test, and the resulting images were
printed out using the HP Printrex 412 thermal printer.

Data Evaluation
The raw values were entered into a Microsoft Excel spreadsheet for further
calculations (a sample is provided in the Appendix section). The recorded peak
(Vs) and mean (Vm) velocities, as well as the pulsatility index (PI) for each
minute were entered; the spreadsheet was designed to calculate automatically the
diastolic velocity using the formula for calculating the pulsatility index as
defined by (Gosling and King, 1974) and solving for the diastolic velocity (Vd) as
below:

Vd = Vs-Vm.PI

All baseline peak velocities (Vs) and pulsatility indices (PI) were averaged to
obtain one baseline value.

When four values per minute were recorded, those

values were averaged as the Vs and PI for that minute; when only a single value
was recorded, that was used for the minute Vs and PI. Those values were further
averaged to result in average post-acetazolamide velocities during the period
after 7-15 minutes, 10-20 minutes and 21-30 minutes.

We observed that the

velocity continued to rise between TO and seven minutes; in all patients, the
increase in velocity had reached a plateau by seven minutes.
The rise in peak velocity was accompanied by a concomitant decrease in the
pulsatility index.

This was caused by the dilation of the resistance arterioles
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distal to the MCA and served as confirmation that the vasomotor response had
occurred.4

Cerebrovascular Reactivity:

The Formula

The highest average post-acetazolamide (post-ACZ) Vs was then compared to
the baseline Vs to obtain the percent cerebrovascular reactivity (CVR), using the
formula below (Ringelstein et al., 1992; Sorteberg et al., 1989):

CVR = %AV =

’(Post-ACZ Vs - baseline Vs)
x 100
baseline Vs

A similar formula was used to obtain the percent change in the pulsatility index
(PI). The ranges of the Vs were also recorded as were the % difference in Vs on
the right as compared to the left. Finally a graph of each minute data point was
generated by the computer.

An example of this data sheet is provided in the

Appendix section.

Follow-Up Studies
Follow-up acetazolamide-reactivity studies were performed on six of the 26
patients. Three patients were re-tested one week after their initial examination
(i.e., approximately 14 days after their ischemic event). Three patients were re¬
examined during a subsequent visit to the outpatient neurology clinic.

The

remainder of the patients did not have follow-up studies, because of refusal to
participate in the follow-up study, failure to keep their outpatient clinic

4The mean velocities and pulsatility indices were not recorded in the patients tested with the
Transpect TCD unit (12 patients). It was decided following this series of patients that those two
parameters might be useful in data confirmation and evaluation, so they are recorded in all
subsequent studies.
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appointment, or because of investigator conflicts with required medical school
classes.

Patient Information Database
Each patient's chart was reviewed after discharge and selected information
was entered into a Double Helix database created by the principal investigator of
this project.

(A blank example of the information sheet is provided in the

Appendix section.)

The information sheet lists basic identification information

about the patient, such as the name, hospital number, age, date of birth, and the
attending and resident physicians who took care of that patient.
Next there is a section in which information pertaining to the study is
recorded. This section includes the date of admission and discharge, the age of
the patient at the time of the event as well as the estimated date of the event
itself. These fields are used to calculate the number of days between the ischemic
event and the reactivity study.

There is also a set of fields for similar

information if a follow-up study was performed. In addition, there is a field each
for the admitting and discharge diagnoses; information entered here is taken
from the printed discharge summary.

At the end of the section there are two

boxed areas in which the highest CVR for each side is recorded; there is a box for
both the initial study and follow-up.
A brief medical history section is included next.

Information entered here

comes directly from the admission history and physical written by the neurology
resident. There are fields for the chief complaint; history of present illness; past
medical history, citing specifically any history of past stroke or heart disease; past
surgical history, in particular any neurological surgeries; history of smoking,
alcohol, or drug abuse; family history, medications, allergies. A physical exam
field is included for any physical findings pertinent to the current illness.

■

'
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Finally, there is a section for course of treatment and progress, which includes
the results from any diagnostic tests (e.g., duplex carotid ultrasound, MRI, CT,
and angiogram).

Classification of Strokes by Type
Subjects were broadly classified by the diagnosis noted at the time of discharge
(ischemic stroke or TIA)5.

The stroke patients were subclassified into lacunar

and non-lacunar strokes, based lesions found by CT or MRI; these classes were
chosen in order to compare strokes of different pathogenesis and prognosis. The
non-lacunar strokes were further divided into deep, superficial, and combined
lesions, so that comparisons between strokes of different sizes could be made.

Statistical Calculation Software
Statistical information used in the reactivity test result sheet are created using
Microsoft Excel 4.0.

All other statistical information was generated using the

InStat v.l software package.

5 Two patients were classified based on the clinical presentation and outcome, instead of the
discharge diagnosis recorded in the medical record. Thus, one patient whose discharge diagnosis
was TIA, suffered a stroke (with residual deficits), and another patient whose diagnosis was stroke
suffered a TIA (i.e. complete resolution of symptoms within 20 minutes of onset). A third patient
who presented with TIAs and underwent reactivity testing suffered a completed stroke one week
following discharge, so he was classified as a stroke patient for this study.

'
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3.

Results

Comparison of the data was made between the stroke patients and those with a
TIA.

Values obtained from both groups were also compared with values in

normal subjects obtained from a previous study (Sorteberg et al., 1989).
Comparisons of the reactivity (CVR) between the symptomatic groups were
made using an unpaired Mann-Whitney test, which does not assume gaussian
distribution of the data.

Comparisons to normal subjects were done using an

unpaired Student's f-test.

3.1

Comparison of Patients with Brain Ischemia

Baseline Peak Velocities
The following table shows the average baseline (pre-acetazolamide) velocities
(± standard deviation) in all stroke patients and all TIA patients.

Table 3-1. Mean Baseline Systolic Velocities (cm/s)
Ipsilateral

Contralateral

(n = 18)

95 (±40)

98 (±53)

Superficial

(n = 9)

105 (±52)

98 (±67)

Deep

(n = 8)

85 (±25)

101 (±43)

Combined

(n = 1)

91 (0)

96 (0)

Lacunar

(n = 4)

73 (±17)

76 (±18)

Non-lacunar

(n = 14)

102 (±43)

105 (±59)

(n = 8)

88 (±20)

89 (±25)

All Strokes

TIA
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The baseline systolic velocities were significantly higher for both stroke and
TIA patients (p < 0.01) than velocities expected in normal subjects (Vs = 65 cm/s ±
6) (Sorteberg et alv 1989).

Post-acetazolamide Peak Velocities
The

following

table

shows

the

average

post-acetazolamide

(post-

acetazolamide) velocities (± standard deviation) in all stroke patients and all TIA
patients.

Table 3-2. Post-acetazolamide Peak Velocities (cm/s)
Ipsilateral

Contralateral

(n = 18)

117 (±44)

128 (±66)

Superficial

(n = 9)

124 (±55)

127 (±84)

Deep

(n = 8)

111 (±35)

133 (±49)

Combined

(n = 1)

99 (0)

98 (0)

Lacunar

(n = 4)

96 (±29)

100 (±31)

Non-lacunar

(n = 14)

122 (±47)

136 (±72)

(n = 8)

120 (±25)

123 (±34)

All Strokes

TIA

The baseline systolic velocities were significantly higher for both stroke
patients (p - 0.01) and TIA patients (p = 0.02) than velocities expected in normal
subjects (Vs = 88 ± 6 cm/s) (Sorteberg et al., 1989).

All Stroke Patients versus All TIA Patients
Stroke patients (n = 18), regardless of the type or location of the lesion,
demonstrated an ipsilateral CVR (±s.d) = 23.79% (±12.19) and a contralateral CVR
= 30.56% (±12.22). TIA patients (n = 8) demonstrated an ipsilateral CVR = 37.05%

'
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(±10.43) and a contralateral CVR = 37.61% (±11.27).

CVR on the affected

(ipsilateral) side was significantly lower (p = 0.02) in stroke patients than in TIA
patients. The unaffected (contralateral) side did not show a significant difference
(p = 0.11).

37.05

37.61
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Type of Ischemic Event
■ Ipsilateral

TIA

aContralateral

Graph 3-1. Comparison of CVR between all stroke patients and those with TIA
for brain hemispheres ipsilateral and contralateral to the side of ischemic event.

Lacunar Infarcts versus Non-lacunar Infarcts
Patients with non-lacunar infarcts (n = 14) showed CVR (±s.d.) = 21.70%
(±11.05) ipsilaterally and CVR = 30.59% (±12.18) contralaterally.

Patients with

lacunar infarcts (n = 3) showed CVR = 38.39% (±3.58) on the ipsilateral side and
CVR = 37.46% (±3.52) contralaterally.

Ipsilateral CVR in patients with non-

'
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lacunar infarcts was significantly lower (p = 0.02) than in patients with lacunar
infarcts. Contralateral CVR was not significant (p = 0.10).6
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Graph 3-2. Comparison of CVR in lacunar and non-lacunar strokes.

Superficial Infarcts versus Deep Infarcts
Patients demonstrating superficial (cortical) infarcts (n = 9) demonstrated a
mean ipsilateral CVR (±s.d.) = 20.21% (±11.90) and contralateral CVR = 31.32%
(±13.36).

Patients with deep (subcortical) infarcts (n = 8) showed a mean

ipsilateral CVR = 29.67% (±10.53) and mean contralateral CVR = 33.28% (±5.81).
Patients with superficial lesions showed significantly lower CVR (p = 0.05) than
patients with deep (sub-cortical) infarcts. Contralateral CVR was not significant
(0.48).

6 One lacunar infarct data point was excluded, because it was considered an outlying point.
Inclusion of this data point made the comparison of lacunar and non-lacunar infarcts slightly not
significant on the affected side.
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Graph 3-3. Comparison of CVR in patients with superficial and deep lesions.

Patients with Combined Deep and Superficial Lesions

Given the small sample size (n = 1), proper statistical comparisons could not
be performed. However, this patient demonstrated one of the lowest CVRs of all
the groups: Ipsilateral CVR = 8.85% and contralateral CVR = 2.07%.

3.2
Comparison of Reactivities in Affected Patients to Previously Studied
Normal Subjects

The following results are comparisons of the patients tested for this study with
normal subjects tested in a previous study (Sorteberg et al., 1989).

The

cerebrovascular reactivity (± standard deviation) demonstrated in normals was
36 ± 9%; this value was used to generate the statistical information given below.
All comparisons were made using an unpaired, two-tailed Student's t-test.
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All Stroke Patients

Side of lesion

n

Mean (%)

± s.d.

p-Value

Ipsilateral

18

23.79

12.19

< 0.01

Contralateral

18

30.56

12.22

0.08

Side of lesion

n

Mean (%)

± s.d.

Ipsilateral

8

37.05

10.43

0.78

Contralateral

8

37.61

11.27

0.70

Side of lesion

n

Mean (%)

± s.d.

Ipsilateral

4

31.10

14.87

0.56

Contralateral

4

30.47

14.26

0.49

Side of lesion

n

Mean (%)

± s.d.

p-Value

Ipsilateral

14

21.70

11.05

< 0.01

Contralateral

14

30.59

12.18

0.12

TIA Patients

p-Value

Lacunar Strokes

p-Value

Non-lacunar Strokes

Strokes with Superficial Lesions

Side of lesion

n

Mean (%)

± s.d.

p-Value

Ipsilateral

9

20.21

11.90

< 0.01

Contralateral

9

31.32

13.36

0.32

Strokes with Deep Lesions
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Side of lesion

n

Mean (%)

± s.d.

Ipsilateral

8

29.67

10.53

0.13

Contralateral

8

33.28

33.28

0.23

p-Value
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4.

Discussion & Conclusion

4.1

Discussion of the Findings

These findings are consistent with the expectation that vasoreactivity is impaired
in acute ischemic brain disease.

What has been seen, however, is that this

impairment is most pronounced in the setting of occlusive disease of
thromboembolic nature, and in cases where there is permanent ischemic
damage. Strokes that occurred secondary to small vessel disease (lacunar strokes)
demonstrated less of a reactivity impairment, if any at all.

Finally, vascular

lesions that affected cortical regions demonstrated worse reactivity than those
affecting sub-cortical regions. These differences are discussed below.

4.1.1

Stroke and TIA

It has been well documented in the literature that stroke patients demonstrate
worse cerebrovascular reactivity that normal patients; TIA patients have not
been extensively studied, however.

The findings here show that, indeed,

reactivity in stroke patients is significantly impaired, which is consistent with the
principle that the resistance arterioles distal to the vessel in question—in this
case the MCA—are maximally dilated and do not respond to an acetazolamide
challenge.
Patients with TIA, on the other hand, tend to show higher reactivity (i.e., less
impaired) values than stroke patients.

Many of these numbers are within the

normal range, although many are slightly impaired.

Thromboembolic and

occlusive disease seem to be major factors in determining the degree to which
reactivity is impaired; patients who experience transient ischemic attacks
demonstrate a wide variety of responses, but the fact that their disease is not yet
severe enough to produce a complete infarct may account for the vasomotor
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reserve capacity to be left largely intact. Impaired reactivity seen in TIA patients
may have some prognostic value, suggesting that further investigation into the
patency of cerebral blood supply may prevent a stroke from occurring.

4.1.2

Lacunar and Non-lacunar Infarcts

Lacunar strokes result from small vessel disease, whereas non-lacunar strokes
occur because of an embolus or pre-existing occlusive disease of the blood
vessels. The artery affected in a lacunar stroke is, therefore, a small branch of a
larger vessel, whereas in a non-lacunar stroke, occlusion of a larger artery creates
a loss in blood flow for all the blood vessels fed by it. Since most of the resistance
arterioles distal to the MCA would be unaffected in a lacunar stroke, they are
probably not maximally dilated.

That would explain why the patients with

lacunar stroke exhibit reactivity similar to that of normal persons.

4.1.3

Superficial, Deep and Combined Lesions

The superficial lesions are caused by processes affecting the larger arteries,
such as the MCA, so that an occlusion would result in its resistance arterioles
being maximally dilated.

Disease in a branch of the larger vessels (e.g.

penetrating branches of the MCA) would not cause a large degree of
compensatory vasodilation, so little change in CVR should be seen when
looking at the MCA, as is seen in these findings. It is likely, however, that if the
branch vessels were tested, a marked decrease in their reactivity would be seen.
Finally, the combined lesions represent the largest extent of disease
(involvement of cortical and non-cortical structures).

Although statistical

analysis was not possible with only one subject, the patient demonstrated
extremely impaired reactivity.

A lesion located in a very proximal segment of

the MCA would account for such a large stroke and for such poor reactivity.

■-
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These findings suggest that increasingly poor reactivity may be associated with
increasingly larger lesions.

4.2

Some Limitations of this Study
This study looked only at the reactivity of the middle cerebral artery (MCA).

What was found that only ischemic strokes that affect the MCA territory
demonstrate markedly impaired reactivity, and that strokes caused by vascular
changes (lacunar strokes) or those affecting other territories may not show
impaired reactivity in the MCA.

Further studies that would be helpful in

investigating the changes in stroke include looking at the reactivity of other
vascular territories (e.g. vertebrobasilar system, posterior cerebral artery, anterior
cerebral artery).

Comparisons could be made after strokes affecting tissues

supplied by these arteries, as well as strokes affecting the other territories.

4.3

Implications of the Findings
What implications do these findings have in understanding some of the

pathophysiology of stroke, and how will this knowledge affect the management
of acute stroke?

The management of acute stroke focuses largely on the re¬

establishment of tissue perfusion through anticoagulation and thrombolysis as
well as strict blood pressure control. With the loss of the brain's autoregulatory
capacity following a stroke, keeping blood pressure slightly elevated and
avoiding, in particular, the lowering of blood pressure may play a key role
improving tissue perfusion. Close monitoring of the autoregulatory capacity can
be achieved by following the cerebral vasoreactivity.

As the brain's

autoregulatory ability returns, and reactivity improves, less strict control on
blood pressure may be possible.

.
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Future Directions and Questions
A number of further investigations should be considered, in light of the

findings presented here.

1.

A look at the reactivity in other vascular territories in order to better
understand the characteristics of vasomotor reserve capacity.

2.

Successive reactivity studies conducted in a series of patients to
determine any significant improvements in reactivity over time.

3.

An unpaired, prospective study comparing stroke patients who receive
standard therapy and those in whom reactivity is used to guide blood
pressure control.

4.5

Concluding Remarks
The intent of this research project was to compare vasomotor reactivity in a

group of patients with cerebrovascular disease.

While there is a great deal of

knowledge that lies ahead, this study has added to scientific knowledge of one of
the processes of brain function.

Further understanding through investigation

will have a positive impact on how patients with cerebrovascular disease are
managed in the future.

*

.
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5.

Appendix:

Data Collection Materials

The pages which follow contain examples of the materials where data were
recorded.

Appendix:

Reactivity Test Result Sheet

TCD REACTIVITY STUDY

5.1

Data Collection Materials

5.1a. Sample of a normal study,
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Appendix:

5.1b. Sample of an abnormal study.
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Patient Information Sheet

REACTIVITY PATIENT INFORMATION
INDENTIFICATION
Last

First

Date of Birth

Unit Number

Age

Attending MD

Sex

Resident MD

STUDY INFORMATION
Date of Admission

Adm Dx

Date of Discharge

Dschg Dx

Est Age of Event
Est Date of Event

Follow-up done?

Date of Study

Date of Follow Up

Days since Event

Days since Event

Initial Reactivity Results
Left

Right

Follow-up Reactivity Results
Right
Left

O Low
OHigh

O Low
OHigh

O Low
OHigh

O Low
OHigh

O Normal
O Abnormal

O Normal
O Abnormal

O Normal
O Abnormal

O Normal
O Abnormal

% CVR:

% CVR:

% CVR:

% CVR:

MEDICAL HISTORY
CC:

HPI:

PMH: l.H/OCVA?

Description:

2. H/O HDz?

Description:

3. Other PMH:

Description:

Appendix:

Data Collection Materials

PSII: 1. Neurol Surg?

Description:

2. Other Surg?

Social Hx: Smoker?
EtOH?
Occptn

Amt/length:
Amt/fq:

Other?

Fam Hx:

l.CVA?

Who?

2. Cardiac?

Who?

3. Other?

Meds:

Allergies:
PE:

Course of Treatment & Progress
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Data Analysis Sheet

PATIENT DATA ANALYSIS
Name:
D/c dx:

Unit #:

Status:
Type:
Location:
Brain level:

Initial
Study

days after
event

F/U
Study

days after
event

Age:

LICA status:
degree:
RICA status:
degree:

Length of time (in
minutes) to absolute
peak velocity:
LMCARMCA-

Time range of greatest
velocity percent increase
from baseline:
LMCARMCA-

Length of time (in
minutes) to absolute
peak velocity:
LMCARMCA-

Time range of greatest
velocity rate of increase
from baseline:
LMCARMCA-

BL

Peak

%CVR

BL

Peak

%CVR

LMCARMCA-

LMCARMCA-

IMAGING STUDIES
Angiogram

CT/MRI
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